EPSILOGEN LTD

W6 9RH (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£786,656

Sep 20 - Dec 22

Preclinical validation of a novel cancer immunotherapeutic

Innovate UK award to EPSILOGEN LTD and

£348,519

Apr 20 - Oct 21

Next generation antibody treatments for ovarian cancer

Innovate UK award to EPSILOGEN LTD and

£523,217

Jan 19 - Nov 20

Innovate UK award to EPSILOGEN LTD and Ian Ardill

£1,018,197

Mar 18 - Jun 20

Innovate UK award to EPSILOGEN LTD and Vivienne Cox